Thursday, 13 August 2020


Chemopharm ramps up efforts to fight COVID-19

10 July 2020 | News

Standard Chartered has committed to provide USD1 billion in financing

Image credit- shutterstock.com

Image credit- shutterstock.com

Chemopharm Sdn Bhd has become the first company in Malaysia to partner with Standard Chartered as part of the Bank’s commitment to financially back manufacturers and distributors who are contributing to the battle against the coronavirus disease.

Standard Chartered’s funding will help Chemopharm ramp up supply of products to meet the increased healthcare demand resulting from the COVID-19 crisis.

Everlife-backed Chemopharm is one of Malaysia’s leading distributors of diagnostic and scientific equipment, which include medical devices and diagnostic kits that could be used in the diagnosis, treatment and monitoring of COVID-19 patients.

Under the initiative, Standard Chartered has committed to provide USD1 billion in financing on a non-profit basis to businesses associated with tackling the pandemic in the form of loans, import and export finance as well as working capital facilities used for daily operations and to get the products to the market.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls